Neuro Centrx is a prominent biopharma company dedicated to providing effective and well-tolerated treatments for individuals with poor mental health. They specialize in developing oral ketamine formulations to address mood disorders like depression, bipolar depression, and other mental health conditions. By collaborating with medicine regulators, Neuro Centrx is seeking approval for a new prescription form of ketamine that acts rapidly to treat depression.

Their immediate-release, abuse-deterrent formulation offers a promising alternative to time-consuming medical procedures currently hindering the prescription of ketamine for depressed patients. Neuro Centrx's commitment to innovation is evidenced by their diverse intellectual property and patents, including abuse-deterrent formulations of controlled substance drug products. The company has completed Phase I trials successfully, treating ten patients with their Keticap formulation under a special license.

Additionally, they have developed two formulations of Keticap for further study. Founded by Dr. Carmel Reilly, Neuro Centrx secured its first investment round in 2014 and patented its initial oral ketamine formulations in 2018.

Through ongoing collaborations, including a Phase I study in partnership with King's College London, Neuro Centrx is advancing towards Phase II and III studies to gain market approval for their Keticap drug product. The brand's board of directors brings extensive experience in drug development, possessing a deep understanding of the pharmaceutical industry. Moreover, Neuro Centrx benefits from a distinguished clinical advisory board, including experts like Professor Allan Young and Professor Metul Mehta, who are at the forefront of research on mood disorders and innovative treatment options.

Neuro Centrx is proud to collaborate with esteemed partners such as Data Magik, Caritas Science Solutions, Rapport, and King's College. Their partnerships contribute to the smooth execution of clinical trials, regulatory guidance, and the overall success of Neuro Centrx in making a significant impact on mental health